This rare genetic disorder affects the seven-transmembrane spanning pseudoprotease iRhom2 (Fig. 1A) and its functions, altering EGF receptor (EGFR) signalling pathways by aggravating iRhom2-dependent ectodomain shedding [12]. This evidence concerns the gene RHBDF2 and hereditary disease.